STAT - Reporting from the frontiers of health and medicine

In the Lab

Health

Health

Pharmalot The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says
First Opinion To thrive, Black and Latinx physicians need their communities
Pharmalot Two dozen big drug makers launch a $1 billion fund to develop new antibiotics
First Opinion It’s time to begin a national wastewater testing program for Covid-19
Health A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

A moment of truth arrives for CytoDyn’s Covid-19 drug. Don’t let spin obscure it
Johnson & Johnson lowers the price of its TB drug in many poor countries, but is it enough?
Eli Lilly’s Dan Skovronsky on Covid-19, Alzheimer’s, and the place of entrepreneurs in pharma

Exclusive

By Matthew Herper and Erin Riglin

On the Front Lines

Health Tech

Health

Health Tech

Special Report

By Gardiner Harris and Alex W. Palmer — The Wire

Health A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price
Health ‘We don’t actually have that answer yet’: WHO clarifies comments on asymptomatic spread of Covid-19
Health The Covid-19 Tracker
Health How likely are kids to get Covid-19? Scientists see a ‘huge puzzle’ without easy answers
Health Fever checks are a flawed way to flag Covid-19 cases. Experts say smell tests might help
First Opinion My Covid-19 symptoms have lasted more than 100 days, and I’m not alone. Will they ever end?
Pharmalot The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says
Health Positive Covid-19 tests kept a mom and baby apart for 55 days. Experts see it as a bigger testing problem